Core A: Administration
核心A:管理
基本信息
- 批准号:10015219
- 负责人:
- 金额:$ 18.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-10 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdministrative PersonnelArizonaBioinformaticsBiometryBudgetsBusinessesCancer CenterClinicCollaborationsCommunicationCommunication ResearchDocumentationEnsureExpenditureFundingGoalsGrantHuman ResourcesInformation DisseminationInstitutionInstitutional Review BoardsLocationOrganization and AdministrationPreventionPrincipal InvestigatorProgress ReportsPublicationsReportingResearchResearch PersonnelResourcesScheduleServicesSkin CarcinomaSupervisionTimeTrainingTravelUnited States National Institutes of HealthUniversitiesUpdateWorkcostmeetingspaymentprogram costsprograms
项目摘要
ABSTRACT
Core A (Curiel, Dong) Administration
The objective of the Administration Core is to provide overall administrative and scientific support for the Program
Project. The Core is responsible for administration and organization, fiscal management, research integration,
communication, research management, and research coordination and is vital to all activities of the Program
Project. The Administration Core interacts directly with each Project and Core in support of this goal. The
administrative functions of this Program Project involve the coordination and integration of the entire proposal.
Dr. Clara Curiel serves as the contact Principal Investigator for this Program and the Leader of the Administration
Core and provides scientific oversight to all Project and Cores. The Administration Core maintains fiscal, as well
as scientific responsibility and provides general day-to-day core support for the Program. The Administration
Core works closely with the University of Arizona Cancer Center Business Office to ensure that timely budget
updates are provided to all investigators. The Core initiates subcontracts with other institutions and reviews
invoices and documentation prior to payment to the subcontractors. The Core approves and allocates funds to
support consultants, travel, and publication costs for the Program. The Core works with the investigators, the
UACC Business Office, and the University of Arizona Sponsored Projects staff to ensure appropriate expenditure
of grant funds. Additionally, the Core coordinates communication within the Program by scheduling twice-
monthly meetings of all investigators and staff to facilitate communication and research collaboration. Additional
meetings coordinated by the Core include meetings with outside consultants and the external Scientific Advisory
Board. These meetings are essential for ensuring consistent communication and collaboration. Administration
Core staff are responsible for reporting activity to the University of Arizona IRB and to the NIH. They also serve
as an administrative and research resource to the Project and Core investigators and staff.
摘要
核心A(Curiel,Dong)给药
行政核心的目标是为该计划提供全面的行政和科学支持
项目核心负责行政和组织、财政管理、研究整合、
沟通、研究管理和研究协调,对该计划的所有活动至关重要
项目管理核心与每个项目和核心直接互动,以支持这一目标。的
本计划项目的管理职能涉及整个建议书的协调和整合。
博士Clara Curiel担任该计划的联系首席研究员和管理领导人
核心,并为所有项目和核心提供科学监督。行政核心保持财政,以及
作为科学责任,并为该计划提供日常核心支持。政府当局
核心与亚利桑那大学癌症中心业务办公室密切合作,以确保及时的预算
向所有调查人员提供最新情况。核心组织发起与其他机构的分包合同,
在向分包商付款之前,提供发票和文件。核心批准并分配资金,
该计划的支持顾问、差旅和出版费用。核心与调查人员合作,
UACC业务办公室和亚利桑那大学赞助项目的工作人员,以确保适当的支出
的赠款资金。此外,核心通过两次调度来协调程序内的通信-
所有研究人员和工作人员每月举行会议,以促进沟通和研究协作。额外
由核心协调的会议包括与外部顾问和外部科学顾问的会议
纸板.这些会议对于确保一致的沟通和协作至关重要。管理
核心工作人员负责向亚利桑那大学IRB和NIH报告活动。他们还提供
作为项目和核心调查员及工作人员的行政和研究资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Clara Curiel-Lewandrowski其他文献
Clara Curiel-Lewandrowski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Clara Curiel-Lewandrowski', 18)}}的其他基金
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin
项目3:TLR4和TOPK抑制剂预防皮肤鳞状细胞癌的转化研究和临床药理学
- 批准号:
10410014 - 财政年份:2019
- 资助金额:
$ 18.39万 - 项目类别:
Targeted Prevention for Non-Melanoma Skin Cancer
非黑色素瘤皮肤癌的针对性预防
- 批准号:
10015212 - 财政年份:2019
- 资助金额:
$ 18.39万 - 项目类别:
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin
项目3:TLR4和TOPK信号通路抑制剂预防皮肤鳞状细胞癌的转化研究和临床药理学
- 批准号:
10252871 - 财政年份:2019
- 资助金额:
$ 18.39万 - 项目类别:
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin
项目3:TLR4和TOPK信号通路抑制剂预防皮肤鳞状细胞癌的转化研究和临床药理学
- 批准号:
10475143 - 财政年份:2019
- 资助金额:
$ 18.39万 - 项目类别:
Targeted Prevention for Non-Melanoma Skin Cancer
非黑色素瘤皮肤癌的针对性预防
- 批准号:
10410013 - 财政年份:2019
- 资助金额:
$ 18.39万 - 项目类别:
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin
项目3:TLR4和TOPK信号通路抑制剂预防皮肤鳞状细胞癌的转化研究和临床药理学
- 批准号:
10015218 - 财政年份:2019
- 资助金额:
$ 18.39万 - 项目类别: